Publications
1–15 of 19 items | Next »
-
Minimizing IV Risk Factors for ICU Patients; Jacobi J.
- Aug 25, 2011 | Pharmacy Purchasing & Products, 2011;16-20.
Safe medication delivery practices cannot be mandated by regulations alone. In hospitals, there are many possible sources of error and this issue is compounded in busy ICU environments where patients are seriously ill. The author describes a “culture of safety” where clinicians point out concerns, work together to seek solutions to problems and design new ways to minimize risks to prevent medication errors.
-
White paper: Inherent Risks in Pharmacy Compunding When Starting from Powder Instead of with FDA Approved Sterile Vials
- Dec 16, 2010 | Lisa L. McChesney-Harris, PhD
- Some pharmacy compounding operations prepare and distribute compounded sterile preparations that
unnecessarily involve high risk, non-sterile powders.
-
APIC position paper: Safe injection, infusion and medication vial practices in healthcare
- Mar 15, 2010 | Association for Professionals in Infection Control
- The transmission of blood borne viruses and other microbial pathogens to patients during routine healthcare procedures continues to occur due to unsafe and improper injection, infusion and medication vial practices . . .
-
Considerations In Pharmacy Compounding And The Treatment Of Spasticity
- Sep 1, 2009 | American Journal of Health-System Pharmacy
- While pharmacy compounding has been an important long-standing tradition of pharmacy practice, allowing physicians to meet individual patient needs, the preparation of compounded sterile products (CSPs) faces continued scrutiny. [AJHP Online membership and registration required.]
-
Considerations in the Treatment Of Spasticity With Intrathecal Baclofen
- Sep 1, 2009 | American Journal of Health-System Pharmacy
- Baclofen injection concentrate for intrathecal administration has FDA-approved labeling for use in patients with severe spasticity who are intolerant or unresponsive to other therapies. Due to its intrathecal delivery, adverse effects are minimized, and patient response is enhanced. Pharmacists should remain knowledgeable about therapy management in patients receiving treatment for spasticity, including adverse event monitoring, infusion device complications, and dosage adjustments.
-
Pharmacy Compounding Of High-Risk Level Products And Patient Safety
- Sep 1, 2009 | American Journal of Health-System Pharmacy
- High-risk level CSPs pose the greatest risk to patients since non-sterile ingredients or containers are used, which mandates final product sterilization prior to dispensing. Pharmacists should understand and comply with federal, state, and USP chapter 797 requirements when preparing CSPs, particularly high-risk level CSPs...
-
Maximizing Outsourcing Options for Compounded Preparations
- Jul 15, 2009 | Pharmacy Purchasing & Products
- Since the initial release of USP <797> in 2004, compounders of sterile preparations have been seeking a balance between ably providing CSPs and safeguarding public health. Pharmacy’s increased focus on compliance efforts has led to increases in pharmacy budgetary spending in the following key areas...
-
Fentanyl Theft Spotlights Need for Tamper-Evident Packaging
- Jul 9, 2009 | 9NEWS
- A former surgical technician may have infected at least 10 people with hepatitis C. The suspect admitted to replacing Fentanyl with saline in various syringes...
-
Intrathecal Therapy For the Management of Cancer and Noncancer Pain
- Mar 16, 2009 | Pain Medicine News
- Intrathecal (IT) drug delivery systems provide analgesia to patients with cancer pain and to those with intractable pain caused by other conditions...
-
Evaluating Outsourced Compounding
- Jan 12, 2009 | Pharmacy Purchasing & Products
- There are many factors that figure into the decision to outsource compounded products. Making the right call is a highly complex decision for pharmacy directors, as it extends well beyond the question of whether outsourcing will simply cost less than keeping the process in-house.
-
Medication Errors Summit
- Dec 15, 2008 | ASHP/AJHP
- Proceedings of a summit on preventing patient harm and death from i.v. medication errors.
-
Special Report: Outsourced Compounding Services To Meet USP Chapter <797> Requirements
- Oct 22, 2008 | Pharmacy Practice News
- Chapter <797> of the United States Pharmacopeia (USP) was initially introduced on January 1, 2004, in an effort to provide a new standard for compounded sterile preparations (CSPs). [Registration Required]
-
Enhanced labeling seeks to ensure proper drug administration
- Sep 15, 2008 | Drug Topics
- A new labeling platform designed to enhance recognition of a medication's name and dose for high-alert, error-prone compounded preparations is getting high marks from health-system pharmacists and patient-safety experts...
-
PharMEDium's Electronic 222 Ordering Initiative
- Sep 1, 2008 | Pharmacy Purchasing & Products
- An overview of PharMEDium's Electronic 222 Ordering Initiative...
-
E222
- Aug 1, 2008 | Drug Topics
- E-Ordering of Controlled Substances more efficient than paper process...
1–15 of 19 items | Next »
Order from PharMEDium
Inquire online
Or call 1(800) 523-7749 for more information on sterile admixture services.